Clinical Trial Update: Dose Response and Receptor Selectivity of Beta-blocker Effects on Bone Metabolism [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 study investigating how different doses and beta-blocker receptor selectivity affect bone metabolism in osteoporosis (age-related) participants…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Osteoporosis
• Osteoporosis

Snippet

Sponsor: Mayo Clinic | Conditions: Osteoporosis, Age-Related | EARLY_Phase 1 | Status: COMPLETED